Acceleration Robotics Launch ROBOTCORE™ to Speed-up ROS 2 Robots
16.6.2022 08:00:00 EEST | Business Wire | Press release
Acceleration Robotics S.L., a robotics semiconductor startup based in the Basque Country and focused on designing customized brains for robots to hasten their response time via FPGAs and GPUs released ROBOTCORE ™, a hardware acceleration framework for the Robot Operating System (ROS), the standard in robotics. Delivering semiconductor building blocks for robots, the company creates custom compute architectures for high performance robots through hardware acceleration while remaining robot and accelerator-agnostic (supporting popular FPGAs and GPUs).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220615005050/en/
ROBOTCORE™ helps build faster compute architectures for robots, or robot cores, that makes robots faster, more deterministic and power-efficient. It provides a development experience for creating robot hardware accelerators similar to the standard ROS development flow. (Photo: Acceleration Robotics)
ROBOTCORE™ allows robotic engineers to create ROS and ROS 2 API-compatible Intellectual Property (IP) cores that increase the robot's performance, including latency and throughput. These “ robot cores” make robots faster, more deterministic and power-efficient. ROBOTCORE™ launches with support for more than 10 development boards, including the most popular hardware acceleration solutions to build robots with ROS.
The framework builds on top of proven open-source software in robotics, such as ROS 2, so that roboticists don't spend time redeveloping what already works and focus instead on delivering higher performance robotic applications. While providing a vendor-agnostic ROS-centric development flow, ROBOTCORE™ solves customer design challenges in robotic areas including sensing, perception, mapping, localization, motion control, low-level control or actuation, with speedups surpassing 500x modern processors.
“Robots are networks of networks, with sensors passing data to compute technologies and actuators. These networks can be understood as the nervous system of the robot. Like with the human nervous system, low latency and real-time information is fundamental for the robot to behave coherently. Faster robots (or with more dexterity) require faster computations. Hardware acceleration with ROBOTCORE™ empowers exactly this. With ROS being the common language roboticists use to build “robot brains”, ROBOTCORE™ extends ROS and deals with GPU and FPGA vendor-proprietary libraries, empowering hardware acceleration across silicon vendors”. – Víctor Mayoral-Vilches, Acceleration Robotics, Founder.
Additional resources
- ROBOTCORE ™ performance benchmarks
- Sign up for Hardware Acceleration News in Robotics
- Join the ROS 2 Hardware Acceleration Working Group
About Acceleration Robotics
Acceleration Robotics is a firm focused on designing customized brains for robots to hasten their response time. Founded by top robotic experts to deliver semiconductor building blocks for robots, the company leverages GPUs and FPGAs to create custom hardware that speeds up a robot's operation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220615005050/en/
Contact information
Víctor Mayoral-Vilches
(+34) 616151561
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLB to Host 2026 Digital Investor Day10.6.2026 15:30:00 EEST | Press release
SLB (NYSE: SLB) will host an Investor Day on Wednesday, June 17, 2026, in New York, where leadership will outline their vision for SLB’s Digital business as digital technologies and AI continue to reshape the energy industry. The presentation will highlight SLB’s integrated digital strategy and portfolio, scalable growth opportunities powered by AI, and financial profile and outlook. Olivier Le Peuch, chief executive officer, SLB, will present at 9:00 a.m. U.S. Eastern Time (ET), and will discuss SLB’s digital strategy and business outlook. Stephane Biguet, chief financial officer, SLB, will present at approximately 11:00 a.m. ET, and will discuss the financial profile of SLB’s Digital business, the market opportunity and SLB’s 2030 digital ambitions. Mr. Le Peuch and Mr. Biguet will be joined by divisional leadership, who will provide further insight into Digital’s competitive differentiation supported by its mission-critical platform, driving transformation for customers. A live webc
Macrobond Launches AI Data Feed with MCP and Skill, Bringing Governed Macroeconomic Intelligence to Enterprise AI Workflows10.6.2026 15:00:00 EEST | Press release
Macrobond today announced the general availability of the Macrobond AI Data Feed Service, a purpose-built product, enabling financial institutions to integrate governed macroeconomic intelligence directly into AI-powered research, investment, and strategy workflows. Available now with MCP, Skill and API delivery components, the AI Data Feed helps organizations accelerate macroeconomic research and insight generation and reduce reliance on fragmented or ungoverned data sources. By delivering reliable, licensed, economic data integrated directly within AI chat interfaces and coding environments, the AI Data Feed Service provides a trusted foundation for enterprise AI initiatives. As generative AI becomes embedded in research, investment, and strategy workflows, face a foundational challenge: most AI systems operate on ungoverned data producing outputs that are difficult to trust, reproduce, or audit. The Macrobond AI Data Feed Service directly addresses this gap by connecting customer’s
Wolters Kluwer expands its Libra AI workspace with authoritative Swiss legal content from leading publisher Stämpfli10.6.2026 15:00:00 EEST | Press release
Wolters Kluwer Legal & Regulatory today announced the expansion of Libra by Wolters Kluwer, its AI-powered legal workspace, to include professional legal content from Stämpfli Publishers, one of Switzerland’s most respected legal publishers. As a result, Swiss legal professionals using Libra by Wolters Kluwer gain direct access to the legal literature that shapes their daily work – fully integrated into a single AI-supported workflow. The content offering includes commentaries, practitioner guides, yearbooks and selected journals from Stämpfli Publishers – including the renowned “Berner Kommentar”, and the company’s succinct commentaries and legal textbooks. In addition, primary sources of Swiss law at both federal and cantonal level are integrated into the workspace. The offering will be continuously expanded over time, with additional titles gradually integrated into the working environment. Libra by Wolters Kluwer provides a fully integrated and secure working environment in which l
Parse Biosciences Launches the Next Generation of its Immune Profiling Kits10.6.2026 15:00:00 EEST | Press release
Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today launched the next generation of its Evercode™ TCR and Evercode™ BCR kits, shipping to customers worldwide. The updated kits deliver a streamlined workflow, better whole transcriptome sequencing library efficiency, and improved performance, enabling researchers to resolve rare clonotypes and profile immune responses at unprecedented scale. Immunology researchers are working to understand complex adaptive immune responses, but meaningful signals are often rare, transient, or difficult to capture across large, sample-limited studies. Parse's immune profiling portfolio combines scale, sensitivity, and fixation-first workflows with paired TCR or BCR and whole transcriptome profiling, helping researchers connect clonal identity to cell state across high-throughput immune studies. Both Evercode TCR and Evercode BCR are now built on the same v4 chemistry that powers the latest Evercode Wh
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region10.6.2026 14:47:00 EEST | Press release
GENESIS Pharma, a leading regional biopharma company focused on the commercialization of innovative medicines in Europe, today announced the expansion of its longstanding commercial partnership with Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), the leading RNAi therapeutics company. The extended agreement broadens the geographical reach of the collaboration to include four Nordic markets -Denmark, Finland, Norway, and Sweden- alongside the thirteen markets in Southeast Europe already within the scope of the partnership. GENESIS Pharma shall commercialize a portfolio of RNAi therapeutics for serious cardiomyopathy conditions and rare genetic diseases across this expanded territory. The partnership, established in 2019 for Southeast Europe, has progressively evolved to encompass a broader portfolio and geographic footprint, covering Greece, Cyprus, Bulgaria, Romania, Slovenia, Croatia, Serbia, Bosnia and Herzegovina, Albania, the Republic of North Macedonia, Montenegro, Malta, and Kosovo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom